Skip to main content
SpringerLink
Log in
Book cover

Practical Manual for Dermatologic and Surgical Melanoma Management pp 15–27Cite as

Melanoma Risk Factors and Prevention

  • Chapter
  • First Online:

  • 450 Accesses

Abstract

Melanoma is the deadliest of skin cancers and its incidence is the highest among non-Hispanic whites, affecting 26 per 100,000 non-Hispanic whites. Incidence among minority groups is lower with 4 per 100,000 in Hispanics, 1 per 100,000 in blacks and 0.5–1.5 per 100,000 in Asians. Although melanoma occurs much less commonly in individuals of color, the survival rate in non-white patients melanoma is significantly lower. For example, between years 2007–2014, the 5-year survival rate was 91% for white patients and 65% for black patients. Here we will identify the risk factors for melanoma and review the screening guidelines for prevention.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1081–6.

    Article  PubMed  Google Scholar 

  2. National Cancer Institute. Surveillance, epidemiology, and end results program. 2018. Available at: https://seer.cancer.gov/statfacts/html/melan.html. Last accessed 6 Mar 2018.

  3. Madankumar R, Gumaste PV, Martires K, et al. Acral melanocytic lesions in the United States: prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patients. J Am Acad Dermatol. 2016;74(4):724–30.

    Article  PubMed  Google Scholar 

  4. Palicka GA, Rhodes AR. Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults. Arch Dermatol. 2010;146(10):1085–94.

    Article  PubMed  Google Scholar 

  5. Dawes SM, Tsai S, Gittleman H, et al. Racial disparities in melanoma survival. J Am Acad Dermatol. 2016;75(5):983–91.

    Article  PubMed  Google Scholar 

  6. American Cancer Society. Cancer facts & figures 2018. Atlanta, GA: American Cancer Society; 2018.

    Google Scholar 

  7. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988–93. Cancer Causes Control. 1997;8(2):246–52.

    Article  CAS  PubMed  Google Scholar 

  8. Byrd KM, Wilson DC, Hoyler SS, et al. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50:21–4; discussion 142–3.

    Article  PubMed  Google Scholar 

  9. Hu S, Parker DF, Thomas AG, et al. Advanced presentation of melanoma in African Americans: the Miami-Dade County experience. J Am Acad Dermatol. 2004;51(6):1031–2.

    Article  PubMed  Google Scholar 

  10. Hu S, Soza-Vento RM, Parker DF, et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol. 2006;142(6):704–8.

    Article  PubMed  Google Scholar 

  11. Hu S, Parmet Y, Allen G, et al. Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol. 2009;145:1369–74.

    PubMed  Google Scholar 

  12. Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166:1907–14.

    Article  PubMed  Google Scholar 

  13. Wu XC, Eide MJ, King J, et al. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999–2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S26–37.

    PubMed  Google Scholar 

  14. Zell JA, Cinar P, Mobasher M, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26(1):66–75.

    Article  PubMed  Google Scholar 

  15. Uprety D, Bista A, Chennamadhavuni A, et al. Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study. Melanoma Res. 2018;28(1):56–60.

    Article  PubMed  Google Scholar 

  16. O’Keefe EB, Meltzer JP, Bethea TN. Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000–2010. Front Public Health. 2015;3:51.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Harvey VM, Patel H, Sandhu S, et al. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes. Cancer Control. 2014;21(4):343–9.

    Article  PubMed  Google Scholar 

  18. Reyes-Ortiz CA, Goodwin JS, Freeman JL, et al. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc. 2006;54:1758–64.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bilimoria KY, Balch CM, Wayne JD, et al. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol. 2009;27(11):1857–63.

    Article  PubMed  Google Scholar 

  20. Chu BS, Koffi W, Hoehn RS, et al. Improvement and persistent disparities in completion lymph node dissection: lessons from the National Cancer Database. J Surg Oncol. 2017;116(8):1176–84.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cokkinides VE, Geller AC, Jemal A. Trends in melanoma mortality among non-Hispanic whites by educational attainment, 1993–2007. Arch Dermatol. 2012;148(5):587–91.

    Article  PubMed  Google Scholar 

  22. Imahiyerobo-Ip J, Ip I, Jamal S, et al. Skin cancer awareness in communities of color. J Am Acad Dermatol. 2011;64(1):198–200.

    Article  PubMed  Google Scholar 

  23. Temoshok L, DiClemente RJ, Sweet DM, et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer. 1984;54(12):3048–53.

    Article  CAS  PubMed  Google Scholar 

  24. Hamilton EC, Nguyen HT, Chang YC, et al. Health disparities influence childhood melanoma stage at diagnosis and outcome. J Pediatr. 2016;175:182–7.

    Article  PubMed  Google Scholar 

  25. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997;277(18):1439–44.

    Article  CAS  PubMed  Google Scholar 

  26. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44.

    Article  PubMed  Google Scholar 

  27. Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by body site. Cancer Epidemiol Biomark Prev. 2005;14(5):1241–4.

    Article  Google Scholar 

  28. Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010;3(2):233–45.

    Article  Google Scholar 

  29. National Cancer Institute. Genetics of skin cancer (P.D.Q.®). 2018. Available at: http://cancer.gov/cancertopics/pdq/genetics/skin/HealthProfessional. Last accessed 6 Mar 2018.

  30. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040–59.

    Article  PubMed  Google Scholar 

  31. Byrd-Miles K, Toombs EL, Peck GL. Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians. J Drugs Dermatol. 2007;6(1):10–6.

    PubMed  Google Scholar 

  32. Hu S, Ma F, Collado-Mesa F, Kirsner RS. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol. 2004;140(7):819–24.

    Article  PubMed  Google Scholar 

  33. Mahendraraj K, Sidhu K, Lau CS, et al. Malignant melanoma in African-Americans: a population-based clinical outcomes study involving 1106 African-American patients from the surveillance, epidemiology, and end result (SEER) database (1988–2011). Medicine (Baltimore). 2017;96(15):e6258.

    Article  Google Scholar 

  34. Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Suppl 1):S78–86.

    PubMed  PubMed Central  Google Scholar 

  35. Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomark Prev. 2010;19(7):1686–95.

    Article  Google Scholar 

  36. Hübner J, Waldmann A, Eisemann N, et al. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Eur J Cancer Prev. 2018;27(6):563–9.

    Google Scholar 

  37. Robbins HA, Clarke CA, Arron ST, et al. Melanoma risk and survival among organ transplant recipients. J Invest Dermatol. 2015;135(11):2657–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Omland SH, Gniadecki R, Hædersdal M, et al. Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study. JAMA Dermatol. 2016;152(2):177–83.

    Article  PubMed  Google Scholar 

  39. Olsen CM, Knight LL, Green AC. Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS One. 2014;9(4):e95096.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Fargnoli MC, Argenziano G, Zalaudek I. High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther. 2006;6(5):657–70.

    Article  CAS  PubMed  Google Scholar 

  41. Cannon-Albright LA, Meyer LJ, Goldgar DE, et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res. 1994;54(23):6041–4.

    CAS  PubMed  Google Scholar 

  42. Bishop JA, Wachsmuth RC, Harland M, et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol. 2000;114(1):28–33.

    Article  CAS  PubMed  Google Scholar 

  43. Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002;94(12):894–903.

    Article  CAS  PubMed  Google Scholar 

  44. Begg CB, Orlow I, Hummer AJ, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst. 2005;97(20):1507–15.

    Article  CAS  PubMed  Google Scholar 

  45. Fargnoli MC, Gandini S, Peris K, et al. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer. 2010;46(8):1413–20.

    Article  CAS  PubMed  Google Scholar 

  46. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12:69–82.

    Article  CAS  PubMed  Google Scholar 

  47. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45–60.

    Article  PubMed  Google Scholar 

  48. Kulichová D, Dáňová J, Kunte C, et al. Risk factors for malignant melanoma and preventive methods. Cutis. 2014;94(5):241–8.

    PubMed  Google Scholar 

  49. IARC Working Group on Artificial UV Light and Skin Cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer. 2007;120:1116–22.

    Google Scholar 

  50. Cust AE, Armstrong BK, Goumas C, et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer. 2011;128(10):2425–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Johnson MM, Leachman SA, Aspinwall LG, et al. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Manag. 2017;4(1):13–37.

    Article  PubMed  PubMed Central  Google Scholar 

  52. U.S. Preventive Services Task Force. Final update summary: skin cancer: counseling. http://uspreventiveservicestaskforce.org.

  53. U.S. Preventive Services Task Force. Final update summary: skin cancer: screening. Available at: http://uspreventiveservicestaskforce.org. Last accessed 4 Jun 2018.

  54. Agency for Healthcare Research and Quality. Screening for skin cancer in adults: an updated systematic evidence review for the U.S. Preventive Services Task Force. Available at: http://uspreventiveservicestaskforce.org. Last accessed 4 Jun 2018.

  55. American Academy of Family Physicians. Skin cancer – Clinical Preventive Service Recommendation. Available at: http://aafp.org/patient-care/clinical. Last accessed 4 Jun 2018.

  56. American Cancer Society. Cancer Facts & Figures 2015. Available at: http://cancer.org/acs/groups/content. Last accessed 4 Jun 2018

  57. American Cancer Society. Cancer Facts & Figures 2016. Available at: https://cancer.org/research. Last accessed 4 Jun 2018

  58. American Academy of Dermatology. AAD statement on USPSTF recommendation on skin cancer screening. 2016. Available at: https://www.aad.org/media/news-releases/aad-statement-on-uspstf. Last accessed 4 Jun 2018.

  59. Skin Cancer Foundation. Prevention guidelines. 2018. Available at: http://skincancer.org/prevention. Last accessed 4 Jun 2018.

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Harbor-UCLA Medical Center, Torrance, CA, USA

    Alison S. Kang

  2. Department of Medicine, The Lundquist Institute, Torrance, CA, USA

    Delphine J. Lee

  3. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Delphine J. Lee

  4. Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA

    Delphine J. Lee

Authors
  1. Alison S. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Delphine J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA

    Delphine J. Lee

  2. Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, CA, USA

    Mark B. Faries

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kang, A.S., Lee, D.J. (2021). Melanoma Risk Factors and Prevention. In: Lee, D., Faries, M. (eds) Practical Manual for Dermatologic and Surgical Melanoma Management. Springer, Cham. https://doi.org/10.1007/978-3-030-27400-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27400-9_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27399-6

  • Online ISBN: 978-3-030-27400-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation